Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q2

4544.TEDINET S100PJXC
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥134.1bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥272.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥133.7bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥17.7bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥27.0bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥17.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥47.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥26.7bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥20.7bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥25.1bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥15.6bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥19.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥15.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥19.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥285.9bnat 2022-09-30Cons.Assets
Total assets¥286.6bnat 2022-03-31Cons.Assets
Total assets¥271.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥128.6bnat 2022-09-30Cons.Liabilities
Total liabilities¥146.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥157.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥140.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥130.9bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥37.3bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥46.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥37.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥41.8bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥43.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥15.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥55.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥20.9bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥18.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥30.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥21.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥9.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥273.422022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥175.172022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥519.552021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥342.232021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥195.932021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥273.382022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥519.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥342.12021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio55.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥5.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥5.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.5bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥85.1bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥85.0bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥83m
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥40.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥35.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5.0bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥15.7bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-09-30¥13.8bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.8bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥10m
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-09-30¥604m
—segment totalrevenue2022-04-01 → 2022-09-30¥139.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥134.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥5.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥19.2bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥4.9bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥4.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥746m
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥88.8bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥88.8bn
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥33m
jpcrp040300-q2r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥14.7bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥35.0bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥30.2bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥4.8bn
jpcrp040300-q2r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥12.0bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2021-04-01 → 2021-09-30¥14.7bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2021-04-01 → 2021-09-30¥14.7bn
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥10m
jpcrp040300-q2r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.0bn
—segment totalrevenue2021-04-01 → 2021-09-30¥138.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥133.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥4.9bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥27.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 532
ItemContextValueUnit
Income before income taxesPrior1YTDDuration25090000000JPY
Income before income taxesCurrentYTDDuration20702000000JPY
Income taxes currentPrior1YTDDuration5511000000JPY
Income taxes currentCurrentYTDDuration2909000000JPY
Income taxes deferredPrior1YTDDuration87000000JPY
Income taxes deferredCurrentYTDDuration2238000000JPY
Income taxesPrior1YTDDuration5598000000JPY
Income taxesCurrentYTDDuration5148000000JPY
Profit lossPrior1YTDDuration19491000000JPY
Profit lossCurrentYTDDuration15553000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-27000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration19519000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration15553000000JPY
Profit lossPrior1YTDDuration19491000000JPY
Profit lossCurrentYTDDuration15553000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration1653000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-1392000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration401000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration6363000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-650000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration101000000JPY
Other comprehensive incomePrior1YTDDuration1404000000JPY
Other comprehensive incomeCurrentYTDDuration5072000000JPY
Comprehensive incomePrior1YTDDuration20896000000JPY
Comprehensive incomeCurrentYTDDuration20626000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration20923000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration20626000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-27000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration25090000000JPY
Income before income taxesCurrentYTDDuration20702000000JPY
Depreciation and amortization ope cfPrior1YTDDuration6712000000JPY
Depreciation and amortization ope cfCurrentYTDDuration9073000000JPY
Amortization of goodwill ope cfPrior1YTDDuration55000000JPY
Amortization of goodwill ope cfCurrentYTDDuration129000000JPY
Foreign exchange losses gains ope cfPrior1YTDDuration-19000000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration-736000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration1052000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration1153000000JPY
Decrease increase in trade receivables and contract assets ope cfPrior1YTDDuration-7303000000JPY
Decrease increase in trade receivables and contract assets ope cfCurrentYTDDuration5806000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-298000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-229000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration71000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-1945000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-1165000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-2025000000JPY
Gain on sales of non current assets ope cfPrior1YTDDuration79000000JPY
Gain on sales of non current assets ope cfCurrentYTDDuration-2615000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass